Researchers performed a two-sample Mendelian randomization analysis to investigate the associations between genetically proxied suppression of PDE5, a recognized pharmacological target for erectile dysfunction, fertility, subjective wellness, and sexual behavior.
Guardant settles allegations it violated the False Claims Act
Dive Brief: Guardant Health will pay almost $914,000 to settle allegations that it violated the False Claims Act without admitting liability. The settlement agreement with
July 23, 2024